
Gene-based blood test may predict melanoma recurrence
April 30, 2025 2 min read Key takeaways: Researchers evaluated a blood test’s ability to predict recurrence in patients with stage 3 melanoma. Approximately 80% of patients with ctDNA levels detected by the blood test experienced recurrence. Monitoring …